If you used Depo-Provera and were later diagnosed with a meningioma or brain tumor, a depo provera lawsuit attorney can help you pursue compensation from Pfizer. This is one of the fastest-growing pharmaceutical mass tort cases in the country right now.
Thousands of women have already filed claims. The litigation is centralized in a federal court in Florida under MDL 3140. Bellwether trials are expected to move forward in 2026.
This guide breaks down everything you need to know. Who qualifies, what the science says, what attorneys do, and what you might recover.
What Does a Depo Provera Lawsuit Attorney Actually Do?
A Depo-Provera lawsuit attorney builds your personal injury case against Pfizer by gathering medical records, proving causation, and negotiating your settlement.
This is not like hiring a traffic lawyer. These attorneys specialize in pharmaceutical product liability. They know how to connect your meningioma diagnosis to your documented Depo-Provera use.
Here is what they handle on your behalf:
- Requesting your injection history from medical providers
- Securing your brain imaging records and surgical reports
- Retaining medical experts to testify about causation
- Filing your complaint into the MDL docket
- Negotiating individually during global settlement discussions
They carry the full weight of the case. You focus on your health.
| Attorney Task | Why It Matters |
|---|---|
| Gathering injection records | Proves duration and dosage of Depo-Provera use |
| Securing MRI and pathology reports | Establishes meningioma diagnosis and severity |
| Retaining expert witnesses | Links medroxyprogesterone acetate to tumor growth |
| Filing into MDL 3140 | Places your claim in the consolidated federal litigation |
| Settlement negotiation | Maximizes your individual recovery |
Most Depo-Provera attorneys work on contingency. That means you pay nothing upfront. They only get paid when you recover money.
How Are Depo Provera Lawsuit Lawyers Different From Regular Attorneys?
Depo-Provera lawsuit lawyers are mass tort specialists, not generalists. The difference matters enormously for your case outcome.
A general personal injury attorney may handle car accidents, slip and falls, and dog bites. Mass tort lawyers spend their careers on pharmaceutical litigation. They already have the expert network, the case infrastructure, and the MDL relationships built.
For a case like this one, experience is not a bonus. It is the deciding factor.
Things that set mass tort attorneys apart:
- They have existing relationships with the MDL plaintiff leadership team
- They understand the specific science behind medroxyprogesterone acetate and meningioma
- They know how bellwether trial results influence individual settlement offers
- They can assess your case tier based on injury severity, usage duration, and age at diagnosis
Think of it like choosing a surgeon. You would not ask your family doctor to remove a brain tumor. You want the specialist who has done this exact procedure hundreds of times.
Bold Fact: The MDL for Depo-Provera, Case No. 3:23-md-3140, is pending in the Middle District of Florida. Attorneys who are already admitted to practice in that MDL have a structural head start.
What Is the Depo Provera Meningioma Lawsuit About?
The Depo-Provera meningioma lawsuit claims that Pfizer knew its injectable contraceptive carried a significantly elevated risk of meningioma brain tumors and failed to warn patients.
Meningioma is a tumor that forms on the membranes surrounding the brain and spinal cord. Most are benign, but they can cause severe symptoms: headaches, vision loss, hearing loss, seizures, and cognitive decline. Some require surgery.
The scientific basis for this lawsuit is strong. A landmark study published in the British Medical Journal in April 2023 found that women who used progestin-based drugs, including medroxyprogesterone acetate (the active ingredient in Depo-Provera), had a significantly higher rate of meningioma compared to non-users. French health regulators at the ANSM had already flagged this risk.
| Key Study Details | Information |
|---|---|
| Publication | British Medical Journal (BMJ), April 2023 |
| Subject | Progestin use and meningioma risk |
| Active ingredient flagged | Medroxyprogesterone acetate (MPA) |
| Regulatory action | French ANSM restricted MPA-based drugs |
| U.S. FDA response | Updated safety communications issued |
Plaintiffs argue that Pfizer had access to this science for years. They chose not to update their warning labels. That failure to warn is at the core of every lawsuit filed.
Key Takeaway: The Depo-Provera meningioma lawsuit is built on documented science and a specific legal theory: Pfizer failed to warn women about a known brain tumor risk linked to the drug’s active ingredient.
Who Qualifies for the Depo Provera Lawsuit?
You likely qualify for the Depo-Provera lawsuit if you received Depo-Provera injections and were later diagnosed with a meningioma or intracranial brain tumor.
The basic qualification framework comes down to four factors: drug use, duration, diagnosis, and timing.
Qualifications at a glance:
- You received Depo-Provera injections (not Depo-subQ Provera 104 specifically, though some attorneys review both)
- You used it for at least one year, though some attorneys accept shorter use periods depending on the case
- You were diagnosed with meningioma after your period of use
- Your diagnosis falls within your state’s statute of limitations window
| Qualification Factor | General Requirement |
|---|---|
| Drug Used | Depo-Provera injectable contraceptive |
| Minimum Duration of Use | At least 12 months (varies by attorney) |
| Qualifying Diagnosis | Meningioma or intracranial brain tumor |
| Timing | Diagnosis after Depo-Provera use began |
| State Deadline | Within your state’s statute of limitations |
Family members of women who died from meningioma after Depo-Provera use may also qualify to file a wrongful death claim.
What Are the Depo Provera Lawsuit Eligibility Requirements?
The Depo-Provera lawsuit eligibility requirements focus on three things: confirmed use of the drug, a meningioma diagnosis supported by medical records, and filing within the legal time limit.
Attorneys reviewing cases in 2026 are looking for the following:
Medical Records You Will Need:
- Pharmacy or clinic records confirming Depo-Provera injections
- MRI or CT scan showing a meningioma or brain tumor
- Biopsy or surgical pathology report (if surgery occurred)
- Treatment records showing any medical intervention
Case Strength Factors Attorneys Evaluate:
- Duration of Depo-Provera use (longer use generally strengthens the case)
- Age at diagnosis (younger plaintiffs with longer potential harm periods may have stronger cases)
- Severity of the meningioma (size, location, whether surgery was required)
- Whether the tumor recurred after treatment
| Eligibility Factor | Impact on Case |
|---|---|
| 1 to 2 years of Depo-Provera use | Moderate case strength |
| 3 to 5 years of use | Strong case |
| 5-plus years of use | Very strong case |
| Meningioma requiring surgery | Higher settlement tier |
| Tumor recurrence or disability | Highest settlement tier |
| No surgery required | Lower but still viable tier |
You do not need to have had surgery to qualify. But surgical cases tend to result in higher compensation.
What Is the Pfizer Depo Provera Lawsuit in 2026?
The Pfizer Depo-Provera lawsuit in 2026 refers to ongoing federal litigation against Pfizer Inc. over its failure to warn about the meningioma risk associated with its injectable contraceptive.
Pfizer acquired Pharmacia in 2003, inheriting Depo-Provera as part of the deal. Since then, Pfizer has been the responsible party for the drug’s labeling, marketing, and warnings.
Plaintiffs argue Pfizer had scientific evidence connecting medroxyprogesterone acetate to meningioma long before it updated any warnings. They claim the company prioritized profits over patient safety.
The litigation includes:
- Individual personal injury lawsuits
- Cases consolidated under MDL 3140 in the Middle District of Florida
- Claims spanning multiple years of Depo-Provera use
Key 2026 Pfizer Lawsuit Facts:
| Detail | Status |
|---|---|
| Defendant | Pfizer Inc. |
| Original Developer | Pharmacia (acquired by Pfizer in 2003) |
| MDL Case Number | 3:23-md-3140 |
| Court | U.S. District Court, Middle District of Florida |
| Presiding Judge | Judge Mary Scriven |
| Legal Theory | Product liability, failure to warn |
Pfizer has not admitted liability. The company is expected to contest causation aggressively through its own expert witnesses.
Key Takeaway: Pfizer is the primary defendant in this litigation. The company acquired Depo-Provera in 2003 and has been responsible for its labeling ever since. Plaintiffs say the warning labels were inadequate given what Pfizer knew about the meningioma risk.
What Side Effects Gave Rise to the Depo Provera Lawsuit?
The Depo-Provera lawsuit is specifically driven by meningioma, a type of brain tumor. This is the central alleged side effect that forms the basis for every filed claim.
Depo-Provera is a progestin-only injectable contraceptive. Its active ingredient, medroxyprogesterone acetate, is a synthetic form of the hormone progesterone. Research has shown that progestin receptors are expressed in meningioma cells. That biological connection is what plaintiffs use to argue causation.
Documented meningioma symptoms that affected plaintiffs report:
- Persistent or worsening headaches
- Vision changes or loss
- Hearing loss or ringing in the ears
- Memory problems and cognitive decline
- Seizures
- Weakness on one side of the body
- Balance and coordination issues
Many women did not connect these symptoms to Depo-Provera. They had no reason to. The drug’s label did not warn them.
| Alleged Side Effect | Medical Description |
|---|---|
| Meningioma | Tumor on membranes surrounding brain or spinal cord |
| Intracranial hypertension | Increased pressure inside the skull |
| Neurological deficits | Cognitive, vision, hearing, and motor impairment |
| Post-surgical complications | Risks from meningioma removal surgery |
The lawsuit does not cover bone density loss, irregular bleeding, or other known Depo-Provera side effects. The meningioma brain tumor claim is the specific focus.
Is the Depo Provera Lawsuit a Class Action?
The Depo-Provera lawsuit is not a traditional class action. It is a mass tort litigation consolidated under a Multidistrict Litigation structure called MDL 3140.
This distinction matters. In a class action, all plaintiffs share one settlement equally. In a mass tort MDL, each plaintiff has their own individual case with their own attorney. Compensation is calculated based on each person’s specific injuries.
Why this is better for most plaintiffs:
- Your payout reflects your specific injury severity, not an average
- Your attorney fights for your individual case facts
- You are not bound by what a class representative negotiated
- Stronger cases recover more money
| Structure | Class Action | Mass Tort MDL |
|---|---|---|
| Individual cases | No, one collective case | Yes, individual cases |
| Individual payout | Equal share of one pot | Based on your injury |
| Your own attorney | Not necessarily | Yes, always |
| Case consolidation | One case in one court | Coordinated pretrial work, individual trials |
| Compensation range | Flat or tiered equally | Wide range based on harm |
MDL 3140 handles Depo-Provera claims from across the country in one federal court. This makes pretrial work more efficient. But each woman’s case stands on its own at settlement time.
Key Takeaway: The Depo-Provera lawsuit is a mass tort MDL, not a class action. Every plaintiff keeps their own case and their own attorney. Your payout is based on your injury, not a shared pool.
What Is the Depo Provera MDL Update for 2026?
As of 2026, MDL 3140 (In re: Depo-Provera Products Liability Litigation) is advancing through the pretrial phase in the Middle District of Florida under Judge Mary Scriven.
The MDL was formally established in late 2023 after courts across the country transferred hundreds of similar cases to a single venue. The case count has grown significantly since then. Estimates put filed cases in the thousands, with many more expected as awareness grows.
Key 2026 MDL developments:
- Discovery is ongoing, with Pfizer producing internal research documents and communications
- Expert witness disclosures from both sides are being scheduled
- The court has set a case management schedule leading toward bellwether trials
- Plaintiff leadership committees are coordinating case selection for bellwether picks
| MDL Milestone | Status in 2026 |
|---|---|
| MDL Established | Late 2023 |
| Presiding Court | M.D. Florida, Tampa Division |
| Presiding Judge | Judge Mary Scriven |
| Discovery Phase | Ongoing as of 2026 |
| Expert Witness Phase | Scheduled for 2026 |
| Bellwether Trial Target | Late 2026 to 2027 |
| Total Cases Filed | Thousands, growing |
The pace of this MDL is comparable to other major pharmaceutical mass torts. The Exactech MDL, the Paragard IUD MDL, and the Essure MDL all moved through similar phases before reaching settlement discussions.
What Are the Depo Provera Bellwether Trials in 2026?
Bellwether trials are test cases selected from the MDL to go to trial first. Their verdicts tell both sides how juries will likely react to the evidence, which drives settlement negotiations.
In MDL 3140, the court and attorneys from both sides are expected to select bellwether cases in 2026. These cases represent a cross-section of the plaintiff pool: different usage durations, different meningioma severities, different age groups.
Here is how bellwether trials typically work:
- A small group of cases (usually 3 to 10) is selected from the MDL pool
- Both sides have input on selection
- Each bellwether goes through full discovery, expert disclosure, and trial
- Results are not binding on other cases but carry enormous psychological weight
- High plaintiff verdicts typically trigger global settlement negotiations
| Bellwether Phase | Expected Timeline |
|---|---|
| Case selection process | 2026 |
| Expert witness preparation | 2026 |
| First bellwether trial | Late 2026 to early 2027 |
| Settlement talks influenced by results | Following first verdict |
| Potential global settlement | 2027 to 2028 |
Attorneys with cases already in the MDL are better positioned to have clients selected as bellwether plaintiffs. That selection can accelerate resolution significantly.
What Is the Latest Depo Provera Lawsuit Settlement Update for 2026?
As of 2026, no global settlement has been reached in the Depo-Provera MDL. The litigation is still in its pretrial phase, and settlement talks of the kind that produce large global agreements have not yet begun.
This is completely normal for a mass tort at this stage. Most large pharmaceutical MDLs do not reach global settlement until after at least one or two bellwether trials produce verdicts. Those verdicts calibrate the settlement value.
What the 2026 landscape looks like:
- Individual case settlements may occur for certain cases
- Pfizer has not offered a global resolution
- Bellwether trials will likely precede any large settlement fund
- Attorneys continue to file new cases and build their client rosters
| Settlement Stage | Status |
|---|---|
| Individual early settlements | Possible for select strong cases |
| Global settlement negotiations | Not yet begun as of 2026 |
| Bellwether verdicts needed first | Yes, likely required |
| Projected global settlement | 2027 to 2028 estimate |
| Settlement administrator appointed | Pending MDL progress |
The Depo-Provera litigation is at a comparable stage to where the 3M Combat Arms earplug MDL was before it exploded into the largest mass tort settlement in U.S. history. Early movement matters.
Key Takeaway: No global Depo-Provera settlement exists yet in 2026. But the MDL is progressing on schedule, and bellwether trials will soon create the pressure needed to bring Pfizer to the settlement table.
How Much Is a Depo Provera Brain Tumor Settlement Worth?
No official Depo-Provera settlement amounts have been announced because no global settlement exists yet. But attorneys and legal analysts project compensation tiers based on comparable pharmaceutical mass tort outcomes.
The most comparable cases include the Essure permanent birth control MDL, the Paragard IUD litigation, and earlier progestin-linked cancer cases.
Projected settlement tier ranges (not guaranteed):
| Injury Tier | Description | Estimated Range |
|---|---|---|
| Tier 1 (Lowest) | Meningioma diagnosed, no surgery required | $50,000 to $150,000 |
| Tier 2 (Moderate) | Surgery required, full recovery | $200,000 to $500,000 |
| Tier 3 (Serious) | Surgery with complications or disability | $500,000 to $1,500,000 |
| Tier 4 (Severe) | Permanent disability or tumor recurrence | $1,500,000 to $3,000,000-plus |
| Wrongful Death | Death from meningioma linked to Depo-Provera | Varies widely by case |
These numbers are estimates drawn from similar drug litigation. Individual results depend on the specific facts of each case, jury tendencies in the trial venue, and Pfizer’s litigation strategy.
A high bellwether verdict could push these numbers significantly higher. A defense win could push them lower.
What Compensation Can You Get From the Depo Provera Lawsuit?
Compensation in the Depo-Provera lawsuit covers multiple categories of harm, not just medical bills.
There are two main types of damages available in pharmaceutical product liability cases:
Compensatory Damages (what you actually lost):
- Past and future medical expenses (surgery, radiation, follow-up care)
- Lost wages and loss of future earning capacity
- Pain and suffering
- Emotional distress
- Loss of enjoyment of life
- Costs of in-home care or assistance
Punitive Damages (punishment for corporate conduct):
- These are awarded on top of compensatory damages
- Courts grant them when a company’s conduct was particularly reckless
- In pharmaceutical cases where internal documents show known risks were suppressed, punitive damages can be substantial
| Damage Category | What It Covers |
|---|---|
| Medical expenses | Surgery, treatment, imaging, future care |
| Lost income | Wages lost during recovery or permanently |
| Pain and suffering | Physical pain, emotional anguish |
| Loss of consortium | Impact on marriage and relationships |
| Punitive damages | Corporate punishment for reckless conduct |
The total compensation picture is broader than most people expect. If you had surgery for meningioma, your medical bills alone can be enormous. Add lost wages and pain and suffering, and the numbers add up fast.
How Much Can You Get From the Depo Provera Lawsuit?
The amount you personally can get from the Depo-Provera lawsuit depends on the severity of your meningioma, how long you used Depo-Provera, and the strength of your medical evidence.
There is no flat amount every plaintiff receives. This is not a class action with equal shares. Your recovery is specific to your case.
Factors that increase your compensation:
- Longer duration of Depo-Provera use (3 or more years)
- Larger or more aggressive meningioma
- Surgery was required for treatment
- Permanent neurological damage or disability
- Young age at diagnosis (longer harm period ahead)
- Strong medical records clearly connecting drug use to diagnosis
Factors that may reduce your compensation:
- Short duration of use
- Small meningioma managed without surgery
- Gaps in medical records or pharmacy records
- State statute of limitations concerns
- Pre-existing conditions affecting causation arguments
| Usage Duration | Estimated Impact on Value |
|---|---|
| Under 1 year | Weak, some attorneys may not accept |
| 1 to 2 years | Moderate, lower tier |
| 3 to 5 years | Strong, mid to upper tier |
| 5-plus years | Strongest cases, highest tiers |
The best way to estimate your personal value is to speak directly with a mass tort attorney who reviews Depo-Provera cases. They will evaluate your specific records.
Key Takeaway: Your individual compensation depends on how seriously you were harmed and how long you used Depo-Provera. Women who required brain surgery after years of use stand to recover the most.
What Is the Depo Provera Lawsuit Filing Deadline in 2026?
The Depo-Provera lawsuit filing deadline is not a single date. Each state has its own statute of limitations for personal injury and product liability claims. Missing your state’s deadline means losing your right to sue permanently.
Most states allow two to three years from the date you discovered or should have discovered the injury. That clock often starts when your meningioma was diagnosed, not when you first took Depo-Provera.
State statute of limitations examples:
| State | Time Limit | Discovery Rule |
|---|---|---|
| California | 2 years | From date of discovery |
| Florida | 2 years | From date of discovery |
| New York | 3 years | From date of injury or discovery |
| Texas | 2 years | From date of discovery |
| Illinois | 2 years | From date of discovery |
| Pennsylvania | 2 years | From date of discovery |
Discovery Rule: In most states, the clock starts when you knew or reasonably should have known that Depo-Provera caused your meningioma. This matters because many women were diagnosed before the public link to Depo-Provera was widely reported.
Waiting costs you money. Early filers are better positioned for bellwether selection and early individual settlement discussions. Filing as soon as possible protects your rights.
How Do You Find a Qualified Depo Provera Attorney?
Finding a qualified Depo-Provera attorney means looking for mass tort specialists who are already actively working Depo-Provera cases in 2026, not general practice firms taking on new case types.
The legal field is full of firms that advertise broadly but lack the infrastructure to handle pharmaceutical mass tort cases properly. Here is what to look for:
Signs of a qualified Depo-Provera attorney:
- They specifically list Depo-Provera or medroxyprogesterone meningioma cases on their website
- They have handled other pharmaceutical mass torts (Paragard, Essure, Paraquat, Zantac)
- They work on contingency with no upfront fees
- They can explain MDL 3140 and where your case fits in the litigation timeline
- They have medical experts and legal staff dedicated to Depo-Provera cases
Questions to ask during your free consultation:
- How many Depo-Provera cases has your firm filed?
- Are you part of the MDL plaintiff leadership or affiliated with those attorneys?
- What do you believe my case is worth based on my records?
- How do you communicate updates throughout the process?
- What is your contingency fee percentage?
| What to Look For | Red Flag |
|---|---|
| Mass tort specialty | General personal injury only |
| Depo-Provera specific experience | First time handling this case type |
| Contingency fee structure | Asking for upfront fees |
| MDL familiarity | Unfamiliar with MDL 3140 |
| Free case evaluation | Charging for initial consultation |
Most reputable mass tort firms offer free case evaluations. You provide your basic information, they review your records, and they tell you whether you have a viable case before you commit to anything.
Frequently Asked Questions
What kind of attorney handles Depo-Provera lawsuits?
A mass tort or pharmaceutical product liability attorney handles Depo-Provera lawsuits.
These are specialists who focus on cases where drugs or medical devices cause serious injuries at scale.
General personal injury attorneys can refer cases, but a mass tort specialist with Depo-Provera experience is the right fit for this litigation.
How long does a Depo-Provera lawsuit take to settle?
Most Depo-Provera lawsuits are expected to take three to five years from filing to settlement.
The MDL was established in late 2023, and bellwether trials are projected for late 2026 into 2027.
Global settlement talks typically begin after bellwether verdicts, meaning payouts may not arrive until 2027 or 2028 for most plaintiffs.
Can I still file a Depo-Provera lawsuit in 2026?
Yes, you can still file a Depo-Provera lawsuit in 2026 if you are within your state’s statute of limitations.
Most states allow two to three years from the date you discovered your meningioma was linked to Depo-Provera.
File as early as possible to protect your rights and improve your position in the litigation.
How much does a Depo-Provera lawsuit attorney cost?
A Depo-Provera lawsuit attorney costs nothing upfront because these cases are handled on contingency.
Attorneys typically charge 33% to 40% of your recovery, taken after you win or settle.
If you do not recover money, the attorney does not get paid.
What evidence do I need to file a Depo-Provera lawsuit?
You need medical records confirming Depo-Provera use and a meningioma or brain tumor diagnosis.
Pharmacy records, clinic injection logs, MRI results, and surgical pathology reports are the core documents.
Your attorney will help gather records you cannot access on your own, including records from providers who have closed.
Where Things Stand and What to Do Right Now
The Depo-Provera litigation is one of the most significant pharmaceutical mass torts active in 2026. The science linking medroxyprogesterone acetate to meningioma is documented. The MDL is moving. Bellwether trials are approaching.
If you used Depo-Provera and received a meningioma diagnosis, time matters. Every state has a deadline. Missing it means losing your right to compensation permanently.
Reach out to a mass tort attorney who handles Depo-Provera cases specifically. Get a free case evaluation. Know where you stand before that window closes.
